The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

被引：0
|
作者：
Sundeep Singh
Shou-jiang Tang
Jayaprakash Sreenarasimhaiah
Luis F. Lara
Ali Siddiqui
机构：
[1] Stanford University,Division of Gastroenterology and Hepatology
[2] University of Mississippi,Division of Digestive Diseases
[3] University of Texas-Southwestern Medical Center,Division of Digestive and Liver Diseases
[4] Baylor University Medical Center,Division of Gastroenterology and Hepatology, Jefferson Digestive Disease Institute
[5] Thomas Jefferson University,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Serum carbohydrate antigen; CA19-9; Pancreatic cancer; Cholangiocarcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2491 / 2496
页数：5
相关论文
共 50 条
  • [31] Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer
    Wu, Lei
    Huang, Peijun
    Wang, Fang
    Li, Daqian
    Xie, Erfu
    Zhang, Yan
    Pan, Shiyang
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (21)
  • [32] New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer
    Luo, Guopei
    Fan, Zhiyao
    Cheng, He
    Jin, Kaizhou
    Guo, Meng
    Lu, Yu
    Yang, Chao
    Fan, Kun
    Huang, Qiuyi
    Long, Jiang
    Liu, Liang
    Xu, Jin
    Lu, Renquan
    Ni, Quanxing
    Warshaw, Andrew L.
    Liu, Chen
    Yu, Xianjun
    PANCREATOLOGY, 2018, 18 (08) : 971 - 976
  • [33] CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
    Luo, Guopei
    Xiao, Zhiwen
    Long, Jiang
    Liu, Zuqiang
    Liu, Liang
    Liu, Chen
    Xu, Jin
    Ni, Quanxing
    Yu, Xianjun
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (12) : 2092 - 2098
  • [34] CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
    Guopei Luo
    Zhiwen Xiao
    Jiang Long
    Zuqiang Liu
    Liang Liu
    Chen Liu
    Jin Xu
    Quanxing Ni
    Xianjun Yu
    Journal of Gastrointestinal Surgery, 2013, 17 : 2092 - 2098
  • [35] The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma
    Jaklitsch, Manuel
    Petrowsky, Henrik
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [36] Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
    Liang, Yao
    Wang, Wei
    Fang, Cheng
    Raj, Seeruttun Sharvesh
    Hu, Wan-Ming
    Li, Qi-Wen
    Zhou, Zhi-Wei
    ONCOTARGET, 2016, 7 (31) : 49565 - 49573
  • [37] DIAGNOSIS OF PANCREATIC-CANCER AND PREDICTION OF UNRESECTABILITY USING THE TUMOR-ASSOCIATED ANTIGEN CA19-9
    FORSMARK, CE
    LAMBIASE, L
    VOGEL, SB
    PANCREAS, 1994, 9 (06) : 731 - 734
  • [38] Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma
    Park, Hyung-Doo
    Kang, Eun-Suk
    Kim, Jong-Won
    Lee, Kyu-Taek
    Lee, Kwang Hyuck
    Park, Young Suk
    Park, Joon-Oh
    Lee, Jeeyun
    Heo, Jin Seok
    Choi, Seong Ho
    Choi, Dong Wook
    Kim, Seonwoo
    Lee, Jong Kyun
    Lee, Soo-Youn
    PROTEOMICS, 2012, 12 (23-24) : 3590 - 3597
  • [39] CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer
    Tang, Jiatong
    Li, Xiaoyang
    Tang, Neng
    Lin, Xiawen
    Du, Yixiang
    Zhang, Shuo
    Li, Qi
    Zhang, Yifan
    Zhang, Yixuan
    Hang, Hexing
    Qiu, Tongtong
    Qiu, Yudong
    Cheng, Hao
    Dai, Zhan
    Hong, Hao
    Wei, Wei
    He, Jian
    Yan, Chao
    CANCER LETTERS, 2025, 622
  • [40] Prognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer
    Jian-Guo Zhao
    Ya Hu
    Quan Liao
    Zhe-Yu Niu
    Yu-Pei Zhao
    World Journal of Gastroenterology, 2014, (19) : 5875 - 5880
12345